Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Albireo Pharma
Albireo Pharma
(ALBO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Bylvay
Odevixibat
2021-07-16
2031-2041
Pruritus
,
Intrahepatic cholestasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Odevixibat
intrahepatic cholestasis
,
liver diseases
,
healthy volunteers/patients
,
biliary liver cirrhosis
,
liver cirrhosis
,
fibrosis
,
pruritus
,
cholestasis
,
alagille syndrome
,
syndrome
Bevifimod
hereditary nephritis
Elobixibat
non-alcoholic fatty liver disease
,
dyslipidemias
,
constipation
Insulin
type 2 diabetes mellitus
,
diabetes mellitus
,
insulin resistance
Viaject
chronic pain
Isoxaflutole
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
covid-19
,
virus diseases
,
sickle cell anemia
,
erectile dysfunction
,
systemic lupus erythematosus
,
psoriatic arthritis
,
arthritis
,
prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
urinary bladder neoplasms
,
uterine neoplasms
,
liver neoplasms
,
kidney neoplasms
,
uterine cervical neoplasms
,
colonic neoplasms
,
hematologic diseases
,
hematopoietic stem cell transplantation
,
bone marrow transplantation
,
acromegaly
,
cardiovascular diseases
,
rare diseases
,
oncogenes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use